REG - Ergomed plc - Directors' Dealing
RNS Number : 0779LErgomed plc16 April 2018Ergomed Plc
("Ergomed" or the "Company")
Directors' Dealing
Ergomed, a profitable UK-based group dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, announces that on 16 April 2018, Dr Miroslav Reljanovic, founder and Executive Vice-Chairman of the Company, sold 4,000,000 ordinary shares of 1p each in the Company ("Share(s)") at a price of 190p per Share to meet institutional demand.
Following this transaction, Dr Miroslav Reljanovic's holding has reduced to 11,132,237 shares (representing 24.9 per cent. of the Company's issued share capital).
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Dr Miroslav Reljanovic
2
Reason for the notification
a)
Position/status
Founder and Executive Vice-Chairman
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Ergomed Plc
b)
Legal Entity Identifier
213800BVS8I9VMC1AP84
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 1 pence each
GB00BN7ZCY67
b)
Nature of the transaction
Sale of shares
c)
Currency
GBP
d)
Price(s) and volume(s)
Price(s)
Volume(s)
190p
4,000,000
e)
Aggregated information
- Aggregated volume
- Price
- Aggregated total
Volume: 4,000,000
Price: 190p
Aggregated volume: £7,600,000
f)
Date of the transaction
16 April 2018
g)
Place of the transaction
London Stock Exchange, AIM
Enquiries:
Ergomed plc
Tel: +44 (0) 1483 503205
Stephen Stamp (Chief Executive Officer)
Numis Securities Limited
Tel: +44 (0) 20 7260 1000
Michael Meade / Freddie Barnfield (Nominated Adviser)
James Black (Joint Broker)
This information is provided by RNSThe company news service from the London Stock ExchangeENDDSHIFMITMBABBJP
Recent news on Ergomed
See all newsREG - Ergomed plc - Cancellation of admission to trading of shares
AnnouncementREG - AIM Ergomed plc - Cancellation - Ergomed plc
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG-Millennium Partners, L.P. Form 8.3 - Ergomed plc
AnnouncementREG - BlackRock Group Ergomed plc - Form 8.3 - Ergomed plc
Announcement